243 related articles for article (PubMed ID: 15631995)
21. Inorganic-polymerization crosslinked tissue-siloxane hybrid as potential biomaterial for bioprosthetic heart valves.
Yang F; He H; Xu L; Jin L; Guo G; Wang Y
J Biomed Mater Res A; 2021 May; 109(5):754-765. PubMed ID: 32681740
[TBL] [Abstract][Full Text] [Related]
22. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials.
Tam H; Zhang W; Feaver KR; Parchment N; Sacks MS; Vyavahare N
Biomaterials; 2015 Oct; 66():83-91. PubMed ID: 26196535
[TBL] [Abstract][Full Text] [Related]
23. ADAPT-treated porcine valve tissue (cusp and wall) versus Medtronic Freestyle and Prima Plus: crosslink stability and calcification behavior in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2004 Jul; 13(4):689-96; discussion 696. PubMed ID: 15311879
[TBL] [Abstract][Full Text] [Related]
24. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride.
Connolly JM; Alferiev I; Kronsteiner A; Lu Z; Levy RJ
J Heart Valve Dis; 2004 May; 13(3):487-93. PubMed ID: 15222297
[TBL] [Abstract][Full Text] [Related]
25. Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: stability and calcification inhibition studies.
Webb CL; Schoen FJ; Levy RJ
Exp Mol Pathol; 1989 Jun; 50(3):291-302. PubMed ID: 2498121
[TBL] [Abstract][Full Text] [Related]
26. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses.
Golomb G; Schoen FJ; Smith MS; Linden J; Dixon M; Levy RJ
Am J Pathol; 1987 Apr; 127(1):122-30. PubMed ID: 3105321
[TBL] [Abstract][Full Text] [Related]
27. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.
Lovekamp JJ; Simionescu DT; Mercuri JJ; Zubiate B; Sacks MS; Vyavahare NR
Biomaterials; 2006 Mar; 27(8):1507-18. PubMed ID: 16144707
[TBL] [Abstract][Full Text] [Related]
28. The effects of the covalent attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl) propyl amine to glutaraldehyde pretreated bovine pericardium on structural degeneration, oxidative modification, and calcification of rat subdermal implants.
Christian AJ; Alferiev IS; Connolly JM; Ischiropoulos H; Levy RJ
J Biomed Mater Res A; 2015 Jul; 103(7):2441-8. PubMed ID: 25546235
[TBL] [Abstract][Full Text] [Related]
29. Mitigated calcification of glutaraldehyde-fixed bovine pericardium by tannic acid in rats.
Wang D; Jiang H; Li J; Zhou JY; Hu SS
Chin Med J (Engl); 2008 Sep; 121(17):1675-9. PubMed ID: 19024098
[TBL] [Abstract][Full Text] [Related]
30. In vivo behavior of epoxy-crosslinked porcine heart valve cusps and walls.
van Wachem PB; Brouwer LA; Zeeman R; Dijkstra PJ; Feijen J; Hendriks M; Cahalan PT; van Luyn MJ
J Biomed Mater Res; 2000; 53(1):18-27. PubMed ID: 10634948
[TBL] [Abstract][Full Text] [Related]
31. Microstructural alterations owing to handling of bovine pericardium to manufacture bioprosthetic heart valves: A potential risk for cusp dehiscence.
Mao J; Wang Y; Philippe E; Cianciulli T; Vesely I; How D; Bourget JM; Germain L; Zhang Z; Guidoin R
Morphologie; 2017 Jun; 101(333):77-87. PubMed ID: 28442174
[TBL] [Abstract][Full Text] [Related]
32. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves.
Leong J; Munnelly A; Liberio B; Cochrane L; Vyavahare N
J Biomater Appl; 2013 May; 27(8):948-60. PubMed ID: 22207605
[TBL] [Abstract][Full Text] [Related]
33. Prevention of calcification of bioprosthetic heart valve cusp and aortic wall with ethanol and aluminum chloride.
Clark JN; Ogle MF; Ashworth P; Bianco RW; Levy RJ
Ann Thorac Surg; 2005 Mar; 79(3):897-904. PubMed ID: 15734402
[TBL] [Abstract][Full Text] [Related]
34. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole.
Pathak YV; Boyd J; Levy RJ; Schoen FJ
Biomaterials; 1990 Nov; 11(9):718-23. PubMed ID: 2128616
[TBL] [Abstract][Full Text] [Related]
35. Effect of alternative crosslinking techniques on the enzymatic degradation of bovine pericardia and their calcification.
Vasudev SC; Chandy T
J Biomed Mater Res; 1997 Jun; 35(3):357-69. PubMed ID: 9138070
[TBL] [Abstract][Full Text] [Related]
36. Exogenous hyaluronic acid and chondroitin sulfate crosslinking treatment for increasing the amount and stability of glycosaminoglycans in bioprosthetic heart valves.
Lei Y; Ning Q; Tang Y; Wang Y
J Mater Sci Mater Med; 2019 Mar; 30(3):38. PubMed ID: 30840150
[TBL] [Abstract][Full Text] [Related]
37. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
38. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
39. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo.
Liu Y; Liu W; Sun G; Wei X; Yi D
Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761
[TBL] [Abstract][Full Text] [Related]
40. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.
Chen W; Kim JD; Schoen FJ; Levy RJ
J Biomed Mater Res; 1994 Dec; 28(12):1485-95. PubMed ID: 7876288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
